1207753-03-4
- Product Name：Ibrexafungerp
- Molecular Formula：C44H67N5O4
- Purity：99%
- Molecular Weight：730.03
Product Details:
CasNo： 1207753-03-4
Molecular Formula： C44H67N5O4
Appearance： White to off-white solid
Delivery Time： 2 weeks after order
Throughput： 100KG/Month
Purity： 99%
Synonyms: SCY-078; MK 3118; MK-3118; 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid,15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-; Ibrexafungerp (SCY-078); Ibrexafungerp(MK-3118),SCY-078; Brexafemme
Boiling point: 815.9±75.0 °C
Density: 1.22±0.1 g/cm3
Pka: 4.69±0.70
Description:
Ibrexafungerp (SCY-078) is an oral and intravenous antifungal drug.
Uses:
Ibrexafungerp is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections.
Relevant Products
-
ApixabanCAS：503612-47-3
-
Ibrexafungerp citrateCAS：1965291-08-0
-
Potassium 2-hydroxy-4-methoxybenzoateCAS：152312-71-5
